ABSTRACT
-
Background
- The incidence of type 1 diabetes mellitus (T1DM) among children is high in Europe and the USA and relatively low in Asia, including Korea. The present study aimed to investigate the incidence and prevalence of childhood-onset T1DM in Korea and examine trends in incidence.
-
Methods
- This study was conducted using the national registry data provided by the Health Insurance Review and Assessment Service in Korea from 2007 to 2017. We included children aged 0 to 14 years who were newly registered with a T1DM diagnosis each year (code E10).
-
Results
- A total of 29,013 children were registered. The overall incidence of T1DM was 4.45 per 100,000 persons (girls, 4.93; boys, 4.01). The overall incidence of childhood-onset T1DM in Korea increased from 3.70 in 2008 to 4.77 in 2016 (P=0.002). The incidence of T1DM increased from 3.07 in 2008 to 4.89 in 2016 (P<0.001) among boys. Although the incidence of the disease increased significantly among boys aged 5–9 and 10–14 years, it remained constant among girls (4.39 in 2008, 4.64 in 2016). The overall prevalence of childhood-onset T1DM in Korea increased from 32.85 in 2007 to 41.03 per 100,000 persons in 2017 (girls, 35.54 to 43.88; boys, 32.85 to 41.03).
-
Conclusion
- We calculated relatively accurate incidence and prevalence of childhood-onset T1DM from a nation-based registry. The incidence increased by 3% to 4% every year from 2007 to 2017. The increasing trend is noteworthy compared with previous reports.
-
Keywords: Diabetes mellitus, type 1; Epidemiology; Incidence; Prevalence
INTRODUCTION
- Childhood-onset type 1 diabetes mellitus (T1DM) is a prevalent pediatric endocrine disease. The incidence and prevalence of T1DM among children are high in Europe (particularly in Scandinavian countries) and the United States of America and relatively low in Asia. The incidence of childhood-onset T1DM has remained less eminent in Asia than in Western countries owing to the paucity of long-term data obtained from population-based studies conducted in Asian countries, including Korea [1].
- An increasing trend in the incidence of childhood-onset T1DM has been reported worldwide. The Diabetes Mondiale (DiaMond) Project Group reported an annual increase in T1DM incidence of 2.8% between 1990 and 1999 [2]. The European Diabetes (EURODIAB) study showed that the incidence of T1DM in Europe increased by approximately 3.9% annually between 1989 and 2003 [3]. The incidence and prevalence of T1DM and type 2 diabetes mellitus (T2DM) are increasing in many developing countries [4,5]. However, recent reports emanating from some countries suggest that this increasing trend has slowed. Studies conducted in Finland and Sweden demonstrated that the incidence of childhood-onset T1DM has ceased to increase in recent years [6,7]. In Norway, there was no significant increase in incidence between 2004 and 2012 [8]. Epidemiological data on T1DM among children and adolescents are still lacking for most of the global population, particularly in Africa, Asia, and South America [2]. Few comprehensive population-based studies of diabetes have investigated children and adolescents of diverse ethnic backgrounds. A few studies have forecasted that the prevalence of childhood-onset T1DM will increase mostly in developing countries, even though the incidence has remained low [9,10]. Surveillance of the incidence and prevalence of childhood-onset T1DM should be conducted not only to understand its complex etiology but also to recognize the implications for public health [11].
- Although several epidemiologic studies have been conducted, it is unclear whether the estimates of incidence and prevalence of T1DM among children and adolescents are accurate and whether the incidence is increasing in Korea. The present study aimed to investigate the incidence and prevalence of childhood-onset T1DM in Korea using the nationwide registry data provided by the Health Insurance Review and Assessment Service (HIRA). We also investigated the annual trend in the incidence of childhood-onset T1DM during the past decade and analyzed the data according to age and sex.
METHODS
- Patients and study design
- The present retrospective population-based study aimed to investigate the incidence and prevalence of childhood-onset T1DM among Korean children through a complete enumeration survey using the HIRA claims data from January 1, 2007 to December 31, 2017. The study design and enrollment of subjects are shown in Fig. 1. Korea has a national health insurance system that provides medical insurance coverage to all its inhabitants, and each individual is registered with a health insurance identification number. Every resident is eligible regardless of nationality or profession. The system is funded by compulsory contributions from all residents and government subsidies. All Korean patients who visit a hospital are registered with a diagnosis according to the World Health Organization’s International Classifications of Diseases, Tenth Revision (ICD-10). The HIRA reviews the data to ensure proper diagnoses and management and to assess the quality of healthcare and medical fees.
- In calculating the incidence of T1DM, we included boys and girls who were newly registered with a diagnostic code of E10 according to the ICD-10 before the age of 15 years and were treated only with insulin, as done in other studies of the pediatric population. We excluded children who were injected with insulin before 2008 and patients who were not treated with insulin continuously for 2 consecutive years after diagnosis to rule out patients with T2DM. In estimating the prevalence, we included children who were registered with a diagnostic code of E10 before the age of 15 years and received at least two prescriptions of insulin over 12 months with continuous insulin treatment in the following year. The diagnosis of T1DM was confirmed with a thorough review of the medical records of all cases by medical personnel of the HIRA.
- Ethics statement
- The study adhered to the tenets of the Declaration of Helsinki. The study protocol was approved by the Institutional Review Board of Severance Hospital, Seoul, Korea, and written informed consents from the subjects were exempted by the IRB (no. 4-2019-0088).
- Calculation of incidence and prevalence
- We calculated the incidence of T1DM by dividing the number of children who were newly diagnosed with T1DM during a calendar year by the total number of children at risk living in Korea during that calendar year. Exact confidence intervals for incidence were calculated using the Ulm’s formula [12]. In addition, we calculated the prevalence of T1DM by dividing the number of children registered with a diagnosis of T1DM during a calendar year by the total number of children living in Korea during that calendar year. The 95% confidence intervals of the prevalence with a 0.05 significance level were also calculated using the formula p±1.96p(1-p)n (where, p is the prevalence and n is the sample size). Gender- and age-specific incidence and prevalence of T1DM were calculated using the population data obtained from the Korean Statistical Information Service, 2015 (http://kosis.kr/). Both the incidence and prevalence were calculated per 100,000 inhabitants according to age and gender. A Cochran–Armitage test for trend was used to investigate and compare the time trends in incidence by sex and age group (0–4, 5–9, and 10–14 years). Analysis items with P<0.05 were considered statistically significant.
RESULTS
- A total of 29,013 children were registered from January 2007 to December 2017. The annual incidences of T1DM according to gender from 2008 to 2016 are shown in Table 1. The overall incidence of T1DM during the study period was 4.45 per 100,000 persons (girls, 4.93; boys, 4.01). The overall incidence of childhood-onset T1DM in Korea increased significantly from 3.70 per 100,000 persons in 2008 to 4.77 per 100,000 persons in 2016 (P=0.002). The incidence of T1DM among boys increased from 3.07 per 100,000 persons in 2008 to 4.89 per 100,000 persons in 2016 (P<0.001). However, the incidence was not definite among girls during the study period (4.39 per 100,000 persons in 2008 and 4.64 per 100,000 persons in 2016). There was an increasing trend in gender-specific annual incidence of childhood-onset T1DM in Korea (Fig. 2). The incidence increased by approximately 3% to 4% every year from 2007 to 2017.
- The annual incidence of T1DM according to gender and age group is shown in Table 2. The overall incidence of childhood-onset T1DM increased significantly among children aged 10 to 14 years. The incidence increased significantly among boys aged 5–9 and 10–14 years; however, it was indefinite among boys aged 0 to 4 years. The incidence of T1DM increased from 1.16 to 3.72 per 100,000 persons among boys aged 5 to 9 years and from 5.53 to 8.90 per 100,000 persons among boys aged 10 to 14 years between 2008 and 2016 (P=0.040 and P<0.001, respectively). The incidence of T1DM among girls did not increase significantly in all age groups.
- The distribution of the annual prevalence of T1DM according to age group is shown in Table 3. The overall prevalence of childhood-onset T1DM in Korea increased significantly from 32.85 to 41.03 per 100,000 persons between 2007 and 2017 (girls, 35.54 to 43.88 per 100,000 persons; boys, 32.85 to 41.03 per 100,000 persons). The annual prevalence increased rapidly over the last 2 years of the study period.
- We analyzed the cumulative distribution of the incidence of disease according to months from 2008 to 2016. The incidence appeared to be relatively high in March, April, and June and low in November and December. However, this seasonal difference was not significant statistically (Fig. 3).
DISCUSSION
- This work was a retrospective national registry-based epidemiologic study of the incidence and prevalence of childhood-onset T1DM in Korea from 2007 to 2017. The overall incidence of childhood-onset T1DM during the study period was 4.45 per 100,000 persons (girls, 4.93; boys, 4.01). The overall incidence of childhood-onset T1DM in Korea (per 100,000 persons) increased significantly from 3.70 in 2008 to 4.77 in 2016 and by approximately 3% to 4% annually during the study period. The overall prevalence (per 100,000 persons) increased significantly from 32.85 in 2007 to 41.03 in 2017 (girls, 35.54 to 43.88; boys, 32.85 to 41.03). We found that the incidence and prevalence of childhood-onset T1DM in Korea were higher than those determined in previous studies conducted in Korea and increased significantly during the study period.
- The global incidence of diabetes among children and adolescents is increasing rapidly due to an increase in incidence of childhood obesity regardless of region. However, there are some variations in the incidence of T1DM according to ethnicity and region. Approximately 193,000 Americans younger than 20 years are estimated to have been diagnosed with diabetes, representing approximately 0.24% of that population [13]. A nationwide survey conducted in the USA from 2001 through 2016 demonstrated that 45,047 people aged 19 or younger who had T1DM were identified, representing a 5.4 to 79.6 prevalence rate per 100,000 person-years according to the states [13]. The DiaMond Project Group reported that a very high incidence was found in European countries and North America, and the lowest incidence was found in the populations from China and South America in 2000 [14]. The EURODIAB study reported the incidence of childhood-onset T1DM in the first (1989 to 1998) and second (1999 to 2008) halves of the 20-year period. The increase in annual incidence rates were similar (3.4% and 3.3%, respectively), suggesting that the incidence rate of childhood-onset T1DM continues to rise across Europe but not uniformly so among the regions [15].
- Asian countries showed relatively lower incidences of childhood-onset T1DM than did Europe and the USA. These geographic differences in T1DM incidence may reflect population variations in the frequency of T1DM susceptibility or protective genes and/or environmental factors or their combination [16]. Although the incidence of T1DM is relatively lower in Asian countries, increasing trends in the incidence of T1DM have also been observed in Asian regions. In Japan, the annual incidence of childhood-onset T1DM was 1.5 per 100,000 persons from 1986 to 1990 [17]. A more recent study conducted in Japan reported that the incidence of T1DM from 2005 to 2010 was 2.25 per 100,000 persons, suggesting that the incidence is increasing in Japan [1]. In China, the incidence in the Beijing area was 1.81 per 100,000 population during 2003 to 2010 [18]. In reports of a Taiwanese nationwide epidemiologic study, the incidence of childhood-onset T1DM (per 100,000 persons) was 3.56 among boys and 5.88 among girls in 1999 to 2000 and increased significantly with an incidence of 4.42 among boys and 6.92 among girls in 2009 to 2010 [19]. The present study showed higher incidence of T1DM in Korea compared with that of Japan and China, and lower than that of Taiwan. The incidence and prevalence of T1DM would differ from country to country due to variable factors including change of lifestyle, increase of obesity, and environmental immune system [20,21].
- It is known that the incidence of childhood-onset T1DM is exceptionally low in Korea. A limited number of studies have estimated the incidence and prevalence of childhood-onset T1DM in Korea. The first nationwide survey on the incidence of T1DM among Korean children and adolescents was conducted as part of the Diabetes Epidemiology Research International Study from 1985 to 1986 and showed an incidence of 0.5 per 100,000 population in both sexes [22]. Another study reported an incidence of 1.36 per 100,000 during 1995 to 2000 [23]. The most recent report on the epidemiology of childhood-onset T1DM in Korea was performed using the data obtained from the National Health Insurance Service during 2012 to 2014 [24]. The incidence was 3.19 per 100,000 (2.84 and 3.56 among boys and girls, respectively), and it was relatively higher than that reported in previous studies conducted in Korea. The present study demonstrated a higher incidence and prevalence than previously reported estimates in Korea and a significant increase in incidence of childhood-onset T1DM. We confirmed that the increasing trend in incidence of childhood-onset T1DM was sustained in Korea.
- In the present study, we found a higher incidence and prevalence among girls than among boys. However, the increase in the rate of incidence was higher among boys. It is known that boys are predominantly affected by T1DM after puberty [25]. The overall ratio of incidence of T1DM among boys to that among girls was 1:1; however, a ratio of 1:7 was reported among children aged 13 years in a study conducted in Finland [26]. Some reports have shown that childhood-onset T1DM is more common among male children and adolescents in European countries [27-29]. Compared with that of Western countries, the Japanese cohort presents a preponderance of girls than boys [17]. A report emanating from China showed a preponderance of girls with newly diagnosed T1DM; however, a higher rate of increase occurred among boys between 1995 and 2010, similar to that observed in the present study [30]. A report showed that female predominance is associated with a lower incidence and ethnic group [27]. This implies that there should be specific considerations according to certain ethnicities or regions, although the reasons remain to be clarified.
- In the present study, the incidences of childhood-onset T1DM appeared to be higher in March, April, and June; however, this seasonal difference was not significant statistically. It has been reported that the incidence of T1DM is higher in the fall or winter seasons [31,32]. However, the seasonality pattern appears to depend on the geographical location, at least as far as the hemisphere dichotomy is concerned [33]. A Japanese cohort study revealed no seasonal variation compared with that of Western countries [17].
- We found that the incidence of childhood-onset T1DM in Korea increased rapidly over the past decade. It is unclear why the incidence of childhood-onset T1DM is increasing in Korea; nevertheless, it is not remarkably higher than that of Western countries. Factors contributing to the development of T1DM include genetic factors, which involve familial and ethnic patterns, and various environmental factors. A westernized lifestyle and national prosperity could reflect differences in environmental risk factors such as nutrition or lifestyle that affect the incidence rate [34]. The “accelerator hypothesis” tried to explain the loss of beta cells and the increasing incidence of both types of diabetes associated with the childhood obesity epidemic in some way [35]. An increasing prevalence of obesity among Korean children may also yield a possible association with the increasing rate of childhood-onset T1DM [36]. An assessment of the risk factors for T1DM in the general population and further efforts aimed at elucidating the causes underlying the increase in incidence of T1DM among Korean children are needed.
- Our study had some limitations. First, some T1DM patients might not be registered for various reasons, such as emigration or studying abroad. Second, there is a possibility of misclassification of childhood T1DM or T2DM. For example, early treatments of T2DM often include insulin injections besides oral hypoglycemic agents. We tried to exclude patients who were not treated with insulin continuously for 2 consecutive years after diagnosis; nonetheless, misclassification might be a confounding factor in the present study. Third, the prevalence might be overestimated. We included children who were registered with a diagnostic code of E10 and were treated with only insulin continuously more than once; however, we could not perfectly exclude some cases of T2DM. Despite these limitations, we believe that the inclusion and exclusion criteria in the present study might be the most practical way to achieve the study aim and we were able to calculate relatively accurate incidences and prevalence of childhood-onset T1DM using the nationwide data.
- In conclusion, we calculated relatively accurate incidences and prevalence of childhood-onset T1DM according to the data obtained from a nationwide registry from the HIRA. We found that the incidence and prevalence of childhood-onset T1DM increased significantly at a rate of about 3% to 4% every year from 2007 to 2017. Further long-term studies with investigation of environmental factors and other possible contributing factors are needed to elucidate the increasing trend in the occurrence of childhood-onset T1DM in Korea.
NOTES
-
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was reported.
-
AUTHOR CONTRIBUTIONS
Conception or design: G.H.S., H.S.K.
Acquisition, analysis, or interpretation of data: H.W.C., G.H.S., S.H., H.S.K.
Drafting the work or revising: H.W.C., K.S., H.S.C., J.S., A.K., H.S.K.
Final approval of the manuscript: H.W.C., G.H.S., K.S., H.S.C., J.S., A.K., S.H., H.S.K.
-
FUNDING
None
Acknowledgements- The authors thank the Yonsei Foreign Language Institute and Editage (www.editage.co.kr) for review and correction of the English version of the manuscript.
Fig. 1.Study design and number of subjects for investigating the incidence of type 1 diabetes mellitus (T1DM) in Korean children. ICD-10, World Health Organization’s International Classifications of Diseases, Tenth Revision.
Fig. 2.Gender-specific annual incidence (per 100,000 persons) of type 1 diabetes mellitus among Korean children.
Fig. 3.Distribution of type 1 diabetes mellitus among Korean children according to month from 2008 to 2016.
Table 1.Gender-specific annual incidence (per 100,000 persons) of type 1 diabetes mellitus with confidence intervals among Korean children
Year |
Girls |
Boys |
Total |
No. of cases |
Population |
Incidence (CI) |
No. of cases |
Population |
Incidence (CI) |
No. of cases |
Population |
Incidence (CI) |
2008 |
181 |
4,120,183 |
4.39 (3.78–5.08) |
139 |
4,521,648 |
3.07 (2.58–3.63) |
320 |
8,881,760 |
3.70 (3.31–4.13) |
2009 |
183 |
4,009,329 |
4.56 (3.93–5.28) |
163 |
4,374,659 |
3.73 (3.18–4.34) |
346 |
8,641,831 |
4.13 (3.70–4.59) |
2010 |
200 |
3,898,029 |
5.13 (4.44–5.89) |
155 |
4,231,154 |
3.66 (3.11–4.29) |
355 |
8,383,987 |
4.37 (3.92–4.85) |
2011 |
223 |
3,799,250 |
5.87 (5.12–6.69) |
172 |
4,106,239 |
4.19 (3.59–4.86) |
395 |
8,129,182 |
5.00 (4.52–5.51) |
2012 |
175 |
3,710,279 |
4.72 (4.04–5.47) |
155 |
3,998,855 |
3.88 (3.29–4.54) |
330 |
7,905,489 |
4.28 (3.83–4.77) |
2013 |
185 |
3,624,293 |
5.10 (4.40–5.90) |
161 |
3,897,014 |
4.13 (3.52–4.82) |
346 |
7,709,134 |
4.60 (4.13–5.11) |
2014 |
195 |
3,541,088 |
5.51 (4.76–6.34) |
163 |
3,795,828 |
4.29 (3.66–5.01) |
358 |
7,521,307 |
4.88 (4.39–5.41) |
2015 |
153 |
3,457,143 |
4.43 (3.75–5.19) |
158 |
3,694,212 |
4.28 (3.64–5.00) |
311 |
7,336,916 |
4.35 (3.88–4.86) |
2016 |
157 |
3,380,577 |
4.64 (3.95–5.43) |
176 |
3,601,440 |
4.89 (4.19–5.66) |
333 |
7,151,354 |
4.77 (4.27–5.31) |
Table 2.Gender-specific annual incidence (per 100,000 persons) of type 1 diabetes mellitus according to age group among Korean children
Variable |
Year |
Girls |
Boys |
Total |
0–4 years |
5–9 years |
10–14 years |
0–14 years |
0–4 years |
5–9 years |
10–14 years |
0–14 years |
0–4 years |
5–9 years |
10–14 years |
0–14 years |
No. of cases |
2008 |
16 |
48 |
117 |
181 |
13 |
25 |
101 |
139 |
29 |
73 |
218 |
320 |
2009 |
21 |
60 |
102 |
183 |
17 |
45 |
101 |
163 |
38 |
105 |
203 |
346 |
2010 |
23 |
60 |
117 |
200 |
20 |
37 |
98 |
155 |
43 |
97 |
215 |
355 |
2011 |
22 |
59 |
142 |
223 |
21 |
48 |
103 |
172 |
43 |
107 |
245 |
395 |
2012 |
16 |
50 |
109 |
175 |
19 |
35 |
101 |
155 |
35 |
85 |
210 |
330 |
2013 |
27 |
46 |
112 |
185 |
16 |
39 |
106 |
161 |
43 |
85 |
218 |
346 |
2014 |
35 |
49 |
111 |
195 |
22 |
35 |
106 |
163 |
57 |
84 |
217 |
358 |
2015 |
26 |
42 |
85 |
153 |
23 |
34 |
101 |
158 |
49 |
76 |
186 |
311 |
2016 |
15 |
56 |
86 |
157 |
20 |
45 |
111 |
176 |
35 |
101 |
197 |
333 |
Incidence |
2008 |
1.44 |
3.49 |
7.17 |
4.39 |
1.09 |
1.66 |
5.53 |
3.07 |
1.26 |
2.53 |
6.30 |
3.70 |
2009 |
1.91 |
4.59 |
6.37 |
4.56 |
1.45 |
3.16 |
5.69 |
3.73 |
1.67 |
3.84 |
6.02 |
4.13 |
2010 |
2.08 |
4.89 |
7.47 |
5.13 |
1.70 |
2.78 |
5.69 |
3.66 |
1.88 |
3.79 |
6.53 |
4.37 |
2011 |
1.96 |
5.12 |
9.31 |
5.87 |
1.76 |
3.85 |
6.18 |
4.19 |
1.86 |
4.46 |
7.68 |
5.00 |
2012 |
1.42 |
4.43 |
7.50 |
4.72 |
1.59 |
2.88 |
6.37 |
3.88 |
1.51 |
3.62 |
6.91 |
4.28 |
2013 |
2.41 |
4.08 |
8.14 |
5.10 |
1.35 |
3.23 |
7.06 |
4.13 |
1.86 |
3.64 |
7.58 |
4.60 |
2014 |
3.13 |
4.39 |
8.49 |
5.51 |
1.86 |
2.94 |
7.44 |
4.29 |
2.48 |
3.64 |
7.94 |
4.88 |
2015 |
2.34 |
3.75 |
6.93 |
4.43 |
1.97 |
2.85 |
7.59 |
4.28 |
2.15 |
3.28 |
7.27 |
4.35 |
2016 |
1.38 |
4.92 |
7.46 |
4.64 |
1.75 |
3.72 |
8.90 |
4.89 |
1.57 |
4.30 |
8.21 |
4.77 |
Cochran–Armitage test for trend |
0.263 |
0.722 |
0.408 |
0.724 |
0.153 |
0.040 |
<0.001 |
<0.001 |
0.072 |
0.103 |
<0.001 |
0.002 |
Table 3.Gender-specific annual prevalence (per 100,000 persons) of type 1 diabetes mellitus with confidence intervals among Korean children
Year |
Girls |
Boys |
Total |
No. of cases |
Population |
Prevalence (CI) |
No. of cases |
Population |
Prevalence (CI) |
No. of cases |
Population |
Prevalence (CI) |
2007 |
1,501 |
4,223,530 |
35.54 (33.76–37.38) |
1,417 |
4,658,230 |
30.42 (28.86–32.05) |
2,918 |
8,881,760 |
32.85 (31.67–34.07) |
2008 |
1,466 |
4,120,183 |
35.58 (33.78–37.45) |
1,361 |
4,521,648 |
30.10 (28.52–31.74) |
2,827 |
8,641,831 |
32.71 (31.52–33.94) |
2009 |
1,416 |
4,009,329 |
35.32 (33.50-37.21) |
1,337 |
4,374,659 |
30.56 (28.95–32.25) |
2,753 |
8,383,987 |
32.84 (31.62–34.09) |
2010 |
1,403 |
3,898,029 |
35.99 (34.13–37.93) |
1,305 |
4,231,154 |
30.84 (29.19–32.56) |
2,708 |
8,129,182 |
33.31 (32.07–34.59) |
2011 |
1,374 |
3,799,250 |
36.17 (34.28–38.13) |
1,233 |
4,106,239 |
30.03 (28.37–31.75) |
2,607 |
7,905,489 |
32.98 (31.72–34.27) |
2012 |
1,400 |
3,710,279 |
37.73 (35.78–39.76) |
1,260 |
3,998,855 |
31.51 (29.79–33.30) |
2,660 |
7,709,134 |
34.50 (33.21–35.84) |
2013 |
1,288 |
3,624,293 |
35.54 (33.62–37.53) |
1,116 |
3,897,014 |
28.64 (26.98–30.37) |
2,404 |
7,521,307 |
31.96 (30.70–33.27) |
2014 |
1,298 |
3,541,088 |
36.66 (34.69–38.71) |
1,117 |
3,795,828 |
29.43 (27.73–31.20) |
2,415 |
7,336,916 |
32.92 (31.62–34.26) |
2015 |
1,201 |
3,457,143 |
34.74 (32.80–36.76) |
1,109 |
3,694,212 |
30.02 (28.28–31.84) |
2,310 |
7,151,354 |
32.30 (31.00–33.65) |
2016 |
1,361 |
3,380,577 |
40.26 (38.15–42.46) |
1,242 |
3,601,440 |
34.49 (32.59–36.46) |
2,603 |
6,982,017 |
37.28 (35.86–38.74) |
2017 |
1,456 |
3,318,119 |
43.88 (41.66–46.19) |
1,352 |
3,526,103 |
38.34 (36.33–40.44) |
2,808 |
6,844,221 |
41.03 (39.52–42.57) |
REFERENCES
- 1. Onda Y, Sugihara S, Ogata T, Yokoya S, Yokoyama T, Tajima N, et al. Incidence and prevalence of childhood-onset type 1 diabetes in Japan: the T1D study. Diabet Med 2017;34:909-15.ArticlePubMedPDF
- 2. DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23:857-66.ArticlePubMed
- 3. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-33.ArticlePubMed
- 4. Aminzadeh M, Navidi N, Valavi E, Aletayeb SMH. Childhood onset type 1 diabetes at a tertiary hospital in south-western Iran during 2000-2015: rapid increase in admissions and high prevalence of DKA at diagnosis. Prim Care Diabetes 2019;13:43-8.ArticlePubMed
- 5. Viswanathan V, Sathyamurthy S. Global increase in the prevalence of diabetes with special reference to the Middle East and Asia. Diabetes Technol Ther 2015;17:676-8.ArticlePubMed
- 6. Harjutsalo V, Sund R, Knip M, Groop PH. Incidence of type 1 diabetes in Finland. JAMA 2013;310:427-8.ArticlePubMed
- 7. Berhan Y, Waernbaum I, Lind T, Mollsten A, Dahlquist G; Swedish Childhood Diabetes Study Group. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes 2011;60:577-81.PubMedPMC
- 8. Skrivarhaug T, Stene LC, Drivvoll AK, Strom H, Joner G; Norwegian Childhood Diabetes Study Group. Incidence of type 1 diabetes in Norway among children aged 0-14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Diabetologia 2014;57:57-62.ArticlePubMedPDF
- 9. Green A. Descriptive epidemiology of type 1 diabetes in youth: incidence, mortality, prevalence, and secular trends. Endocr Res 2008;33:1-15.ArticlePubMed
- 10. Basit A, Riaz M, Fawwad A. Improving diabetes care in developing countries: the example of Pakistan. Diabetes Res Clin Pract 2015;107:224-32.ArticlePubMed
- 11. Dabelea D. The accelerating epidemic of childhood diabetes. Lancet 2009;373:1999-2000.ArticlePubMed
- 12. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 1990;131:373-5.PubMedPDF
- 13. Rogers MAM, Rogers BS, Basu T. Prevalence of type 1 diabetes among people aged 19 and younger in the United States. Prev Chronic Dis 2018;15:E143.ArticlePubMedPMC
- 14. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000;23:1516-26.ArticlePubMedPDF
- 15. Patterson CC, Gyurus E, Rosenbauer J, Cinek O, Neu A, Schober E, et al. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 2012;55:2142-7.ArticlePubMedPDF
- 16. Kawasaki E, Matsuura N, Eguchi K. Type 1 diabetes in Japan. Diabetologia 2006;49:828-36.ArticlePubMedPDF
- 17. Kida K, Mimura G, Ito T, Murakami K, Ashkenazi I, Laron Z. Incidence of type 1 diabetes mellitus in children aged 0-14 in Japan, 1986-1990, including an analysis for seasonality of onset and month of birth: JDS study. The Data Committee for Childhood Diabetes of the Japan Diabetes Society (JDS). Diabet Med 2000;17:59-63.ArticlePubMed
- 18. Gong C, Meng X, Saenger P, Wu D, Cao B, Wu D, et al. Trends in the incidence of childhood type 1 diabetes mellitus in Beijing based on hospitalization data from 1995 to 2010. Horm Res Paediatr 2013;80:328-34.ArticlePubMedPDF
- 19. Lin WH, Wang MC, Wang WM, Yang DC, Lam CF, Roan JN, et al. Incidence of and mortality from type I diabetes in Taiwan from 1999 through 2010: a nationwide cohort study. PLoS One 2014;9:e86172.ArticlePubMedPMC
- 20. Soltesz G, Patterson CC, Dahlquist G; EURODIAB Study Group. Worldwide childhood type 1 diabetes incidence: what can we learn from epidemiology? Pediatr Diabetes 2007;8 Suppl 6:6-14.ArticlePubMed
- 21. Jarosz-Chobot P, Polanska J, Polanski A. Does social-economical transformation influence the incidence of type 1 diabetes mellitus? A Polish example. Pediatr Diabetes 2008;9:202-7.ArticlePubMed
- 22. Rewers M, LaPorte RE, King H, Tuomilehto J. Trends in the prevalence and incidence of diabetes: insulin-dependent diabetes mellitus in childhood. World Health Stat Q 1988;41:179-89.PubMed
- 23. Shin CH. Epidemiologic characteristics of type 1 diabetes in children aged 14 years or under in Korea, 1985-2000. Korean J Pediatr 2008;51:569-75.Article
- 24. Kim JH, Lee CG, Lee YA, Yang SW, Shin CH. Increasing incidence of type 1 diabetes among Korean children and adolescents: analysis of data from a nationwide registry in Korea. Pediatr Diabetes 2016;17:519-24.ArticlePubMed
- 25. Kyvik KO, Nystrom L, Gorus F, Songini M, Oestman J, Castell C, et al. The epidemiology of type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 2004;47:377-84.ArticlePubMedPDF
- 26. Harjutsalo V, Sjoberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371:1777-82.ArticlePubMed
- 27. Karvonen M, Pitkaniemi M, Pitkaniemi J, Kohtamaki K, Tajima N, Tuomilehto J. Sex difference in the incidence of insulin-dependent diabetes mellitus: an analysis of the recent epidemiological data. World Health Organization DIAMOND Project Group. Diabetes Metab Rev 1997;13:275-91.ArticlePubMed
- 28. Gonzalez EL, Johansson S, Wallander MA, Rodriguez LA. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009;63:332-6.ArticlePubMed
- 29. Bruno G, Maule M, Merletti F, Novelli G, Falorni A, Iannilli A, et al. Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study. Diabetes 2010;59:2281-7.PubMedPMC
- 30. Gong C, Meng X, Jiang Y, Wang X, Cui H, Chen X. Trends in childhood type 1 diabetes mellitus incidence in Beijing from 1995 to 2010: a retrospective multicenter study based on hospitalization data. Diabetes Technol Ther 2015;17:159-65.ArticlePubMed
- 31. Van Wouwe JP, Jacobusse G, Van Buuren S. Seasonal variation in the diagnosis of type 1 diabetes. Diabetes Res Clin Pract 2008;79:e13.Article
- 32. Patterson CC, Gyurus E, Rosenbauer J, Cinek O, Neu A, Schober E, et al. Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centers during 1989-2008: little short-term influence of sunshine hours or average temperature. Pediatr Diabetes 2015;16:573-80.ArticlePubMed
- 33. Moltchanova EV, Schreier N, Lammi N, Karvonen M. Seasonal variation of diagnosis of type 1 diabetes mellitus in children worldwide. Diabet Med 2009;26:673-8.ArticlePubMed
- 34. Patterson CC, Dahlquist G, Soltesz G, Green A; EURODIAB ACE Study Group. Europe and Diabetes. Europe and Diabetes. Is childhood-onset type I diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia 2001;44 Suppl 3:B9-16.
- 35. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 2001;44:914-22.ArticlePubMedPDF
- 36. Ha KH, Kim DJ. Epidemiology of childhood obesity in Korea. Endocrinol Metab (Seoul) 2016;31:510-8.ArticlePubMedPMCPDF
Citations
Citations to this article as recorded by
- Risk of non-thyroidal autoimmune diseases in patients with Graves’ disease: a nationwide retrospective cohort study
Seo Young Sohn, Jiyeon Ahn, Min Kyung Lee, Jae Hyuk Lee, Ji-Won Kwon, Ji-Min Kweon, Ju-Yeun Lee
Rheumatology.2024;[Epub] CrossRef - Effectiveness of Non-pharmacological Interventions for Adolescents With Type 1 Diabetes in the Last Five Years: A Systematic Review and Meta-analysis
DaeEun Lee, Haejung Lee, YoonYoung Shin, Gaeun Park
Asian Nursing Research.2024; 18(1): 51. CrossRef - Development and Testing of the School Healthcare Partnership Scale for Parents
Ju-Yeon Uhm, Suhee Kim
Western Journal of Nursing Research.2024; 46(3): 219. CrossRef - Research Trends in Family-Centered Care for Children With Chronic Disease
YeoJin Im, Sunyoung Jung, YoungAh Park, Jeong Hee Eom
CIN: Computers, Informatics, Nursing.2024;[Epub] CrossRef - Association Between Benzene and Other Volatile Organic Compounds Exposure and Diabetes Mellitus Among Korean Adults: Findings from the Nationwide Biomonitoring Data
Seong-Uk Baek, Minseo Choi, Yu-Min Lee, Jin-Ha Yoon
Exposure and Health.2024;[Epub] CrossRef - Do Type 1 and Type 2 Diabetes Have the Same Vascular Complications?
Yun Kyung Cho
The Journal of Korean Diabetes.2024; 25(2): 62. CrossRef - Islet transplantation in Korea
Joonyub Lee, Kun‐Ho Yoon
Journal of Diabetes Investigation.2024; 15(9): 1165. CrossRef - Association Between Type 1 Diabetes Mellitus and Incident Gastrointestinal Cancer in Korean Population: A Nationwide Retrospective Cohort Study
Soonsu Shin, Min‐Ho Kim, Chang‐Mo Oh, Eunhee Ha, Jae‐Hong Ryoo
Diabetes/Metabolism Research and Reviews.2024;[Epub] CrossRef - Changes in the Epidemiological Landscape of Diabetes in South Korea: Trends in Prevalence, Incidence, and Healthcare Expenditures
Kyoung Hwa Ha, Dae Jung Kim
Endocrinology and Metabolism.2024; 39(5): 669. CrossRef - Trends in incidence rates of childhood type 1 diabetes mellitus: A retrospective study in Isfahan province, Iran
Mahin Hashemipour, Mohammadreza Maracy, Shaghayegh Haghjooy Javanmard, Farzane Zamaneh, Neda Mostofizadeh, Silva Hovsepian
Journal of Diabetes Investigation.2023; 14(3): 376. CrossRef - Incidence of Childhood Type 1 Diabetes in Beijing During 2011–2020 and Predicted Incidence for 2025–2035: A Multicenter, Hospitalization-Based Study
Yuchuan Li, Kun Qian, Di Wu, Xinli Wang, Hong Cui, Geheng Yuan, Jinfang Yuan, Lijun Yang, Liya Wei, Bingyan Cao, Chang Su, Xuejun Liang, Min Liu, Wenjing Li, Miao Qin, Jiajia Chen, Xi Meng, Rui Wang, Shan Su, Xiaobo Chen, Hui Chen, Chunxiu Gong
Diabetes Therapy.2023; 14(3): 519. CrossRef - Utilization of nutrition labels and related factors among patients with diabetes in Korea
So-Jung Lee, Mi Ah Han, Jong Park, So Yeon Ryu
Nutrition Research and Practice.2023; 17(2): 297. CrossRef - Long-term trends of pediatric type 1 diabetes incidence in Japan before and after the COVID-19 pandemic
Fumika Matsuda, Tomoyo Itonaga, Miwako Maeda, Kenji Ihara
Scientific Reports.2023;[Epub] CrossRef - The burdens faced by parents of preschoolers with type 1 diabetes mellitus: an integrative review
Sunyeob Choi, Hyewon Shin
Child Health Nursing Research.2023; 29(3): 166. CrossRef - Hypoglycemic Effect of an Herbal Decoction (Modified Gangsimtang) in a Patient with Severe Type 2 Diabetes Mellitus Refusing Oral Anti-Diabetic Medication: A Case Report
Sungjun Joo, Hyonjun Chun, Jisu Lee, Seungmin Seo, Jungmin Lee, Jungtae Leem
Medicina.2023; 59(11): 1919. CrossRef - Improving self-management and diabetes indicators in adolescents with type 1 diabetes through self-care education
Narges Asghari, Bahman Dashtebozorgi, Shahnaz Rostami, Saeed Ghanbari, Kourosh Riahi-Ghahfarokhi
Journal of Family Medicine and Primary Care.2023; 12(10): 2322. CrossRef - Механізм дії та особливості застосування холекальциферолу в дітей та підлітків на етапах розвитку цукрового діабету 1-го типу
V.V. Popova, N.V. Het´man, Ya.I. Labanets, H.V. Kulikovs´ka, O.V. Furmanova, K.P. Zak
Endokrynologia.2023; 28(1): 36. CrossRef - Comparison of Initial Presentation of Pediatric Diabetes Before and During the Coronavirus Disease 2019 Pandemic Era
Yoonha Lee, Minseung Kim, Kyeongeun Oh, Eungu Kang, Young-Jun Rhie, Jieun Lee, Yong Hee Hong, Young-Lim Shin, Jae Hyun Kim
Journal of Korean Medical Science.2022;[Epub] CrossRef - Recent information on test utilization and intraindividual change in anti-glutamic acid decarboxylase antibody in Korea: a retrospective study
Rihwa Choi, Wonseo Park, Gayoung Chun, Jiwon Lee, Sang Gon Lee, Eun Hee Lee
BMJ Open Diabetes Research & Care.2022; 10(3): e002739. CrossRef - Comparison of the clinical characteristics and outcomes of pediatric patients with and without diabetic ketoacidosis at the time of type 1 diabetes diagnosis
Young-Jun Seo, Chang Dae Kum, Jung Gi Rho, Young Suk Shim, Hae Sang Lee, Jin Soon Hwang
Annals of Pediatric Endocrinology & Metabolism.2022; 27(2): 126. CrossRef - Prevalence trends of type 1 and type 2 diabetes in children and adolescents in North Rhine-Westphalia, the most populous federal state in Germany, 2002-2020
C. Baechle, A. Stahl-Pehe, N. Prinz, T. Meissner, C. Kamrath, R.W. Holl, J. Rosenbauer
Diabetes Research and Clinical Practice.2022; 190: 109995. CrossRef - Diabetic ketoacidosis in children with new-onset type 1 diabetes mellitus: demographics, risk factors and outcome: an 11 year review in Hong Kong
Sarah Wing-yiu Poon, Joanna Yuet-ling Tung, Wilfred Hing-sang Wong, Pik-to Cheung, Antony Chun-cheung Fu, Gloria Shir-wey Pang, Sharon Wing-yan To, Lap-ming Wong, Wai-yu Wong, Suk-yan Chan, Ho-chung Yau, Wing-shan See, Betty Wai-man But, Shirley Man-yee W
Journal of Pediatric Endocrinology and Metabolism.2022; 35(9): 1132. CrossRef - School Nurse–Parent Partnership in School Health Care for Children with Type 1 Diabetes: A Hybrid Method Concept Analysis
Ju-Yeon Uhm, Mi-Young Choi
Asian Nursing Research.2022; 16(5): 282. CrossRef - Increased Incidence of Pediatric Diabetic Ketoacidosis After COVID-19: A Two-Center Retrospective Study in Korea
Min Jeong Han, Jun Ho Heo
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 783. CrossRef - Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus (Diabetes Metab J 2021;45:46-54)
Ye Seul Yang, Tae Seo Sohn
Diabetes & Metabolism Journal.2021; 45(2): 277. CrossRef - Relationships between emissions of toxic airborne molecules and type 1 diabetes incidence in children: An ecologic study
Agostino Di Ciaula, Piero Portincasa
World Journal of Diabetes.2021; 12(5): 673. CrossRef - Diagnosis and management of pediatric type 1 diabetes mellitus
Jieun Lee
Journal of the Korean Medical Association.2021; 64(6): 425. CrossRef - Diabetes in Adolescence, Appropriate Transition to Adult Clinic
Jieun Lee, Jae Hyun Kim
The Journal of Korean Diabetes.2021; 22(2): 77. CrossRef - Trajectories in glycated hemoglobin and body mass index in children and adolescents with diabetes using the common data model
Yun Jeong Lee, Sooyoung Yoo, Soyoung Yi, Seok Kim, Chunggak Lee, Jihoon Cho, Soyeon Ahn, Sunkyu Choi, Hee Hwang, Young Ah Lee, Choong Ho Shin, Hyung-Jin Yoon, Kwangsoo Kim, Eunhye Song, Jin Ho Choi, Han Wook Yoo, Young-Hak Kim, Ji Seon Oh, Eun-Ae Kang, Ga
Scientific Reports.2021;[Epub] CrossRef - What Affects Quality of Life for People with Type 1 Diabetes?: A Cross-Sectional Observational Study
Mi-Kyoung Cho, Mi-Young Kim
International Journal of Environmental Research and Public Health.2021; 18(14): 7623. CrossRef - The Relationship between Diabetes Family Conflict and Parental Conflict on Problem Recognition in Illness Self-Management among Individuals with Type 1 Diabetes Mellitus
Mi-Kyoung Cho, Mi Young Kim
International Journal of Environmental Research and Public Health.2021; 18(17): 8914. CrossRef - Relationship between Diabetes Family Conflicts or Problem Recognition in Illness Self-Management and Quality of Life of Adolescents with T1DM and Their Parents
Mi-Kyoung Cho, Mi Young Kim
International Journal of Environmental Research and Public Health.2021; 18(20): 10710. CrossRef - Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
Sun Joon Moon, Inha Jung, Cheol-Young Park
Diabetes & Metabolism Journal.2021; 45(6): 813. CrossRef - History of insulin treatment of pediatric patients with diabetes in Korea
Jae Hyun Kim, Choong Ho Shin, Sei Won Yang
Annals of Pediatric Endocrinology & Metabolism.2021; 26(4): 237. CrossRef - A Position Statement of the Utilization and Support Status of Continuous Glucose Monitoring in Korea
Won Jun Kim, Jae Hyun Kim, Hye Jin Yoo, Jang Won Son, Ah Reum Khang, Su Kyoung Kwon, Ji Hye Kim, Tae Ho Kim, Ohk Hyun Ryu, Kyeong Hye Park, Sun Ok Song, Kang-Woo Lee, Woo Je Lee, Jung Hwa Jung, Ho-Chan Cho, Min Jeong Gu, Jeongrim Lee, Dal Lae Ju, Yeon Hee
The Journal of Korean Diabetes.2021; 22(4): 225. CrossRef